Familial Hypertrophic cardiomyopathy: The Same Mutation, Different Prognosis. Comparison of Two Families with a Long Follow-up;Miocardiopatia Hipertrófica Familiar: A Mesma Mutação, Diferente Expressão Fenotípica. Estudo Comparativo de Duas Famílias

Revista Portuguesa de Cardiologia

Volumn 22, Issue 12, 2003, Pages 1445-1461

  Brito, Dulce ^a   Richard, Pascale ^a   Isnard, Richard ^a   Pipa, João ^a   Komajda, Michel ^a   Madeira, Hugo ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Beta myosin heavy chain gene mutations; Familial hypertrophic cardiomyopathy; Genetics; Genotype phenotype relationship

Indexed keywords

ISOLEUCINE; MYOSIN HEAVY CHAIN; THREONINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FAMILY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; PORTUGAL; PROGNOSIS; RISK FACTOR; SUDDEN DEATH;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOSIN HEAVY CHAINS; PHENOTYPE; PORTUGAL; PROGNOSIS; PROTEIN ISOFORMS;

EID: 0842307583     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995;92:1336-47.
2. Wigle ED. The diagnosis of hypertrophic cardiomyopathy. Heart 2001;86:709-71.
3. McKenna W, Behr ER. Hypertrophic cardiomyopathy: management, risk stratification and prevention of sudden death. Heart 2002;87:169-76.
4. Cuda G, Lamberti A, Perrotti N et al. Familial hypertrophic cardiomyopathy: molecular basis and genotype-phenotype correlations. Rev Port Cardiol 1998;17(Supl II):21-31.
5. Maron BJ, Gardin JM, Flack Jm et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995;92:785-9.
6. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-85.
7. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20:1-8.
8. Towbin J, Roberts R. Cardiovascular diseases due to genetic abnormalities. In: Schlant RC, Alexander RW, eds. Hurst's The Heart: Arteries and Veins. New York, NY: McGraw Hill, Inc 1994:1725-59.
9. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982;65:1388-94.
10. McKenna W, Deanfield J, Farugui A et al. Prognosis in hypertrophic cardiomyopathy: role of age and clinical electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-8.
11. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol, 1986;7:204-14.
12. Maron BJ, Spirito P, Wesley YE et al. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986;315:610-4.
13. Spirito P, Chiarella F, Carratino L et al. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989;320:749-55.
14. Wigle ED, Rakowski H, Kimball BP et al. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995;92:1680-92.
15. Vulpian A. Contribution à l'étude des rétré cissements de l'orifice ventriculo-aortique. Archives de Physiologie 1868;3:456-7.
16. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20:1-8.
17. Hollman A, Goodwin JF, Teare D, Renwick JW. A family with obstructive cardiomyopathy (asymmetrical hypertrophy). Br Heart J 1960;22:449-56.
18. Clarck CE, Henry WL, Epstein SE. Familial prevalence and genetic transmission of idiopathic hypertrophic cardiomyopathy. N Engl J Med 1973;289:709-14.
19. Van Dorp WG, Ten Cate FJ, Vletter WB et al. Familial prevalence of asymmetric septal hypertrophy. Eur J Cardiol 1976;4:349-57.
20. Jarcho JA, Mckenna W, Pare JAP et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989;321:1372-8.
21. Geisterfer-Lowrance AAT, Kass S, Tanigawa G et al. A molecular basis for a familial hypertrophic cardiomyopathy: a B cardiac myosin heavy-chain gene missense mutation. Cell 1990;62:999-1006.
22. Maron BJ, Nichols PF3rd, Pickle LW et al. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-Mode and two-dimensional echocardiography. Am J Cardiol 1984;53:1087-94.
23. Solomon SD, Simonette W, Watkins H et al. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the B-myosin heavy chain gene. J Am Coll Cardiol 1993;22:498-505.
24. Fananapazir L. Advances in molecular genetics and management of hypertrophic cardiomyopathy. JAMA 1999;281 (18):1746-52.
25. Bonne G, Carrier L, Richard P et al. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res 1998;83:580-93.
26. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical B-myosin heavy-chain gene mutations. Circulation 1994;89:22-32.
27. Dubourg O, Isnard R, Hagège A et al. Doppler echocardiography in familial hypertrophic cardiomyopathy: the French Cooperative Study. Echocardiography 1995;12:235-40.
28. Charron P, Dubourg O, Desnos M et al. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J 1998;19:139-45.
29. Davignon A, Rautaharju PM, Boisselle E et al. Normal ECG standard for infants and children. Ped Cardiol 1979;1:123-31.
30. Bonne G, Carrier L, Bercovici J et al. Cardiac myosin binding protein-C gene acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995;11:438-40
31. Dausse E, Komajda M, Fetler L et al. Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of an hot spot mutations in the B-myosin heavy chain gene. J Clin Invest 1993;92:2507-13.
32. Richard P, Tesson F, Hainque B et al. B-myosin heavy chain mutations screening in 18 unrelated families with familial hypertrophic cardiomyopathy (Abstr). J Mol Cell Cardiol 1996;28:A65.
33. Tesson F, Richard P, Charron P et al. Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy. Human Mutat 1998;12(6):385-92.
34. Jaenicke T, Diederich KW, Haas W et al. The complete sequence of the human B-myosin heavy chain gene and a comparative analysis of its product. Genomics 1990;8:194-206.
35. Mercadier JJ, Bouveret P, Gorza L et al. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ Res 1983;53:52-62.
36. Watkins H, McKenna WJ, Thierfelder L et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-64.
37. Warrick HM, Spudich JA. Myosin structure and function in cell motility. Annu Rev Cell Biol 1987;3:379-421.
38. Watkins H, Thierfelder L, Anan R et al. Independent origin of identical B cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. Am J Hum Genet 1993;53:1180-5.
39. Watkins H, Rosenzweig A, Hwang DS et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-14.
40. Jaaskelainen P, Soranta M, Miettinen R et al. The cardiac B-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Cardiol 1998;32(6):1709-16.
41. Machida M. Genetic heterogeneity of hypertrophic cardiomyopathy in Japanese. Hokkaido Igaku Zasshi 1994;69:1024-34.
42. Gonçalves LM, Vieira M, Faro C et al. Identification of an Arg403Gln beta myosin heavy chain gene mutation in a Portuguese family with hypertrophic cardiomyopathy. Rev Port Cardiol 2000;19(4):431-43.
43. Richard P, Charron P, Leclercq C et al. Homozygotes for a R869G mutation in the beta-myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000;32(8):1575-83.
44. Richard P, Isnard R, Carrier L et al. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet 1999;36(7):542-5.
45. Arbustini E, Fasani R, Morbini P et al. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart 1998;80(6):548-58.
46. Charron P, Dubourg O, Desnos M et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997;96:214-9.
47. Varnava A, Baboonian C, Davison F et al. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 1999;82(5):621-4.
48. Fananapazir L, Epstein ND. Prevalence of hypertrophic cardiomyopathy and limitations of screening methods. Circulation 1995;92(4):700-4.
49. Lechin M, Quiñones MA, Omran A et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-12.
50. Tesson F, Dufour C, Moolman JC et al. The influence of the angiotensin-I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol 1997;29:831-8.
51. Brugada R, Kelsey W, Lechin M et al. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Invest Med 1997;45:542-5.
52. Osterop AP, Koffland MJ, Sandkuijl LA et al. AT1 receptor A/C 1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension 1998;32:825-30.
53. Marian AJ. Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 2002;17(3):242-52.
54. Marian AJ, Yu QT, Workman R et al. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-6.